NPMc⁺ is similar to t(8;21) and inv(16) in predicting favorable outcome in FLT3/ITD negative patients. Kaplan-Meier estimates of event-free survival (EFS) and overall survival (OS) in patients lacking FLT3/ITD mutations. Log-rank P values are shown.